TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,738 | -66.8% | 550 | -93.0% | 0.00% | – |
| Q2 2023 | $5,228 | +84.5% | 7,909 | +122.8% | 0.00% | – |
| Q1 2023 | $2,833 | -99.4% | 3,550 | -98.2% | 0.00% | – |
| Q4 2022 | $456,145 | +3701.2% | 201,834 | +3118.0% | 0.00% | – |
| Q3 2022 | $12,000 | -96.6% | 6,272 | -93.4% | 0.00% | – |
| Q2 2022 | $352,000 | -20.5% | 94,560 | +39.1% | 0.00% | – |
| Q1 2022 | $443,000 | -25.4% | 67,980 | +33.2% | 0.00% | – |
| Q4 2021 | $594,000 | -4.5% | 51,036 | +52.9% | 0.00% | – |
| Q3 2021 | $622,000 | +455.4% | 33,383 | +529.9% | 0.00% | – |
| Q2 2021 | $112,000 | -84.8% | 5,300 | -85.4% | 0.00% | – |
| Q1 2021 | $735,000 | -22.6% | 36,211 | +1.3% | 0.00% | – |
| Q4 2020 | $949,000 | +284.2% | 35,749 | +225.0% | 0.00% | – |
| Q3 2020 | $247,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |